GULP1 regulates the NRF2-KEAP1 signaling axis in urothelial carcinoma.


Journal

Science signaling
ISSN: 1937-9145
Titre abrégé: Sci Signal
Pays: United States
ID NLM: 101465400

Informations de publication

Date de publication:
18 08 2020
Historique:
entrez: 21 8 2020
pubmed: 21 8 2020
medline: 3 11 2021
Statut: epublish

Résumé

Disruption of the KEAP1-NRF2 pathway results in the transactivation of NRF2 target genes, consequently inducing cell proliferation and other phenotypic changes in cancer cells. Here, we demonstrated that GULP1 was a KEAP1-binding protein that maintained actin cytoskeleton architecture and helped KEAP1 to sequester NRF2 in the cytoplasm. In urothelial carcinoma of the bladder (UCB), silencing of GULP1 facilitated the nuclear accumulation of NRF2, led to constitutive activation of NRF2 signaling, and conferred resistance to the platinum drug cisplatin. Knockdown of GULP1 in UCB cells promoted tumor cell proliferation in vitro and enhanced tumor growth in vivo. In primary UCB, GULP1 silencing was more prevalent in muscle-invasive UCB compared to nonmuscle-invasive UCB. GULP1 knockdown cells showed resistance to cisplatin treatment. In parallel with decreased

Identifiants

pubmed: 32817372
pii: 13/645/eaba0443
doi: 10.1126/scisignal.aba0443
pii:
doi:

Substances chimiques

Adaptor Proteins, Signal Transducing 0
GULP1 protein, human 0
KEAP1 protein, human 0
Kelch-Like ECH-Associated Protein 1 0
NF-E2-Related Factor 2 0
NFE2L2 protein, human 0

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : NCI NIH HHS
ID : P50 CA098252
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA163594
Pays : United States

Informations de copyright

Copyright © 2020 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works.

Auteurs

Masamichi Hayashi (M)

Department of Otolaryngology-Head and Neck Surgery, Johns Hopkins University School of Medicine, Baltimore, MD 21231, USA.
Department of Gastroenterological Surgery, Nagoya University Graduate School of Medicine, 65 Tsurumai-cho, Showa-ku, Nagoya, Aichi 466-8550, Japan.

Elisa Guida (E)

Department of Otolaryngology-Head and Neck Surgery, Johns Hopkins University School of Medicine, Baltimore, MD 21231, USA.

Yoshikuni Inokawa (Y)

Department of Otolaryngology-Head and Neck Surgery, Johns Hopkins University School of Medicine, Baltimore, MD 21231, USA.
Department of Gastroenterological Surgery, Nagoya University Graduate School of Medicine, 65 Tsurumai-cho, Showa-ku, Nagoya, Aichi 466-8550, Japan.

Rachel Goldberg (R)

Department of Otolaryngology-Head and Neck Surgery, Johns Hopkins University School of Medicine, Baltimore, MD 21231, USA.

Leonardo O Reis (LO)

Department of Urology, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA.

Akira Ooki (A)

Department of Otolaryngology-Head and Neck Surgery, Johns Hopkins University School of Medicine, Baltimore, MD 21231, USA.

Manohar Pilli (M)

Department of Environmental Health Sciences, School of Public Health, Johns Hopkins University, Baltimore, MD 21205, USA.

Pritam Sadhukhan (P)

Department of Otolaryngology-Head and Neck Surgery, Johns Hopkins University School of Medicine, Baltimore, MD 21231, USA.

Juhyung Woo (J)

Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA.

Woonyoung Choi (W)

Johns Hopkins Greenberg Bladder Cancer Institute, Johns Hopkins University, Baltimore, MD 21287, USA.

Evgeny Izumchenko (E)

Department of Otolaryngology-Head and Neck Surgery, Johns Hopkins University School of Medicine, Baltimore, MD 21231, USA.
Department of Medicine, Section of Hematology/Oncology, University of Chicago, Chicago, IL 60637, USA.

Leonel Maldonado Gonzalez (LM)

Department of Otolaryngology-Head and Neck Surgery, Johns Hopkins University School of Medicine, Baltimore, MD 21231, USA.
Department of Gynecology and Obstetrics-Gynecologic Specialties, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA.

Luigi Marchionni (L)

Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA.

Alex Zhavoronkov (A)

Insilico Medicine Inc., Emerging Technology Centers, Johns Hopkins University at Eastern, B301, 1101 33rd Street, Baltimore, MD 21218, USA.

Mariana Brait (M)

Department of Otolaryngology-Head and Neck Surgery, Johns Hopkins University School of Medicine, Baltimore, MD 21231, USA.
Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA.

Trinity Bivalacqua (T)

Department of Urology, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA.

Alexander Baras (A)

Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA.

George J Netto (GJ)

Department of Urology, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA.
Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA.
Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA.

Wayne Koch (W)

Department of Otolaryngology-Head and Neck Surgery, Johns Hopkins University School of Medicine, Baltimore, MD 21231, USA.

Anju Singh (A)

Department of Environmental Health Sciences, School of Public Health, Johns Hopkins University, Baltimore, MD 21205, USA.

Mohammad O Hoque (MO)

Department of Otolaryngology-Head and Neck Surgery, Johns Hopkins University School of Medicine, Baltimore, MD 21231, USA. mhoque1@jhmi.edu.
Department of Urology, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA.
Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH